H₂-Receptor Antagonist
Pregnancy: Compatible — H₂ receptor antagonists considered safe in pregnancy (preferred over PPIs in first trimester).
Famotidine
Brand names: Pepcid, Antodine
Adult dose
Dose: Peptic ulcer: 40mg at night for 4–8 weeks (maintenance 20mg at night). GORD: 20mg BD for 6–12 weeks. Dyspepsia: 20mg BD.
Route: Oral
Frequency: Once at night (peptic ulcer) or twice daily (GORD/dyspepsia)
Max: 40mg twice daily (GORD — maximum)
H₂-receptor antagonist — second-line to PPIs. Fewer drug interactions than cimetidine. Useful when PPIs contraindicated or not tolerated. Onset within 1 hour; duration up to 10–12 hours.
Paediatric dose
Dose: 0.5 mg/kg
Route: Oral
Frequency: Twice daily
Max: 40mg per dose
BNF for Children: 1–17 years: 0.5mg/kg BD (max 20mg per dose). GORD: 1–3 months (unlicensed): 0.5mg/kg BD. Source: BNF for Children 2024.
Dose adjustments
Renal
eGFR <30: reduce dose to 20mg at night or every 36–48 hours. Risk of CNS side effects in severe renal impairment.
Hepatic
No dose adjustment required in hepatic impairment.
Paediatric weight-based calculator
BNF for Children: 1–17 years: 0.5mg/kg BD (max 20mg per dose). GORD: 1–3 months (unlicensed): 0.5mg/kg BD. Source: BNF for Children 2024.
Clinical pearls
- Preferred H₂RA over cimetidine — fewer drug interactions (cimetidine inhibits CYP1A2, CYP2C9, CYP2D6, CYP3A4; famotidine does not).
- H₂RA tolerance (tachyphylaxis): efficacy decreases with regular use after 2–4 weeks — not suitable for long-term acid suppression.
- Useful as step-down from PPI when long-term acid suppression no longer required at full PPI level.
- OTC-available in UK (Pepcid 10mg) for dyspepsia — prescribe generically.
Contraindications
- Known hypersensitivity to H₂-receptor antagonists
Side effects
- Headache, dizziness
- Constipation or diarrhoea
- Confusion (especially in elderly or renal impairment — CNS penetration)
- QT prolongation (rare, at high doses)
Interactions
- Atazanavir: reduced antiretroviral absorption — separate doses by ≥10 hours
- Ketoconazole / itraconazole: reduced absorption (acid-dependent)
- Warfarin: minimal interaction (unlike cimetidine)
Monitoring
- Symptom response
- Renal function (adjust dose if eGFR falls <30)
Reference: BNFc; BNF 90; NICE CG17 GORD; SPC Pepcid. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021